Endogenous cysteine protease inhibitors in upmost pathogenic parasitic protozoa

Microbiol Res. 2022 Aug:261:127061. doi: 10.1016/j.micres.2022.127061. Epub 2022 May 11.

Abstract

The regulation of the activity of proteases by endogenous inhibitors is a common trend in almost all forms of life. Here, we review the endogenous inhibitors of cysteine proteases of three major pathogenic parasitic protozoa. The review focuses on members of the genus Plasmodium, Entamoeba, and Leishmania. Research in this domain has revealed the presence of only chagasin-like inhibitors of cysteine proteases that house a β-barrel immunoglobulin-fold and inhibit the target proteases using a 3-loop inhibitory mechanism in these pathogens. Inhibitors of cysteine proteases are highly evolvable enzymes that target a broad spectrum of pathogenic cysteine proteases with a proclivity for those involved in host-parasite interactions. A common trend reflects a limited sequence homology between cysteine proteases and their inhibitors. The inhibitors are also known to participate in other housekeeping functions of the parasites. Generalizations about their roles are thus best avoided. In this review, the reader will find comprehensive information on the cellular localization of inhibitors of cysteine proteases, their structure, function, and the associated mechanisms of action. The reader will also find a thorough analysis of the role of these inhibitors in parasite pathology and the common trends interlinking them with parasite biology and evolution.

Keywords: Amoebiasis; Cysteine protease; Enzyme inhibitor; Leishmaniasis; Malaria.

Publication types

  • Review

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Cysteine Proteases*
  • Cysteine Proteinase Inhibitors / pharmacology
  • Parasites*
  • Protozoan Proteins

Substances

  • Cysteine Proteinase Inhibitors
  • Protozoan Proteins
  • Cysteine Proteases